The Antitrust Prescription Archive
- Blog, 05.30.2023
In this edition of The Antitrust Prescription, our Pharmaceutical Economics team discusses Merck and Glenmark's settlements with direct purchasers, end payors, and retailers worth over a combined $600 million.
- Blog, 03.15.2023
In this article, Dr. George Korenko and Dr. Tram Nguyen discuss a brief history of the numerosity standards and the potential implications of recent decisions in pharmaceutical antitrust matters.